SSRIs can trigger headaches, including migraines, though the overall risk increase is modest. A large meta-analysis of second-generation antidepressants found that SSRIs raised the relative risk of headache by about 6% compared to placebo, a statistically borderline effect that varied considerably by drug. The connection runs through serotonin, the same neurotransmitter involved in both depression and migraine pathways, which makes the relationship between these medications and head pain more tangled than a simple side-effect listing might suggest.
What the Evidence Says About SSRIs and Headaches
The clearest data comes from a meta-analysis published in the Journal of Affective Disorders, which pooled results from randomized controlled trials of second-generation antidepressants. SSRIs as a class showed a small but statistically significant increase in headache risk compared to placebo. Not all SSRIs carried equal risk, though. When the researchers looked at individual drugs, escitalopram stood out with a roughly 18% higher risk of headache versus placebo. Bupropion, which is not an SSRI but a different type of antidepressant, showed an even higher headache risk at about 22%. Other SSRIs like fluoxetine, sertraline, and paroxetine did not individually reach statistical significance for increased headache risk.1PubMed. Meta-analysis: Second generation antidepressants and headache
A US claims study looking at real-world prescribing data found that headache was the single most common side effect reported among new antidepressant users, occurring at rates up to 17 per 1,000 person-months of therapy in both adults and adolescents.2PubMed. Rates of 5 common antidepressant side effects among new adult and adolescent cases of depression: a retrospective US claims study That number sounds small in absolute terms, and it is. For most people starting an SSRI, headache is not the defining experience. But for someone who already lives with migraines, even a small nudge toward more frequent or intense head pain can feel significant.
It is worth noting that these studies tracked “headache” broadly, not migraines specifically. Clinical trials rarely break out migraine as a separate adverse event from tension-type headache or other head pain. So when your prescriber says SSRIs “can cause headaches,” the evidence supporting that statement is real but doesn’t tell you with precision whether the headache you’re experiencing is a migraine, a tension headache, or something else entirely.
Why Serotonin Makes This Complicated
Serotonin sits at the crossroads of both conditions. SSRIs work by blocking the reabsorption of serotonin, leaving more of it available in the spaces between nerve cells. That extra serotonin is what eventually helps lift depression and reduce anxiety. But serotonin also plays a central role in migraine. Serotonin receptors line the trigeminal nerve and the blood vessels around the brain, and activating certain serotonin receptors is actually the mechanism behind triptans, the most widely used acute migraine medications.3PubMed Central. Serotonin and CGRP in migraine
When you first start an SSRI, the sudden rise in serotonin levels triggers feedback mechanisms that temporarily dial down how much serotonin your neurons fire. Over weeks of treatment, the brain adapts and firing rates return closer to normal.4PubMed Central. Delayed Antidepressant Efficacy and the Desensitization Hypothesis This adjustment period is when many side effects, headaches included, tend to be worst. The brain’s serotonin system is essentially recalibrating, and until it settles into a new equilibrium, you may experience disruptions in pain signaling, blood vessel tone, and other serotonin-mediated functions.
There is some debate about how completely this recalibration happens. Animal research has shown that even after two weeks of continuous SSRI treatment, the brain’s feedback receptors still function and still restrain serotonin release, rather than fully “shutting off” as some models predicted.5PubMed. Autoreceptors remain functional after prolonged treatment with a serotonin reuptake inhibitor This means the serotonin system stays in a modified state throughout treatment, not a static one. For some people, that ongoing modification may subtly influence headache patterns even after the initial adjustment period has passed.
The Timing Factor: Starting, Adjusting, and Stopping
Most SSRI-related headaches show up in the first few weeks of treatment. If you have just started an SSRI or recently had your dose increased, a new headache pattern is more likely tied to the medication change than if you have been on a stable dose for months. Many prescribers will counsel patience during this window because the headaches frequently fade as your system adjusts.
Stopping an SSRI can also bring headaches, sometimes severe ones. Discontinuation syndrome is well documented across the SSRI class, and headache is one of its hallmark symptoms. A case report in the otolaryngology literature described a patient who developed daily, prolonged episodes of vertigo, headaches, tinnitus, and nausea within days of stopping citalopram.6Otolaryngology Case Reports. Vestibular migraine and SSRI withdrawal: A case report That is an extreme case, but it illustrates the general principle: abrupt discontinuation is riskier than gradual tapering. If you and your doctor decide to stop an SSRI, a slow step-down schedule reduces the chance of rebound headaches and other withdrawal-like symptoms.
Switching between antidepressants introduces its own risk window. Conservative switching strategies involve gradually tapering the first drug, allowing a washout period, and then slowly starting the new one.7PubMed Central. Switching and stopping antidepressants During this transition, headaches can appear either because you are withdrawing from the old medication or adjusting to the new one, or both at once. If you are prone to migraines, flagging that history with your prescriber before any medication change is worth doing.
SSRIs Are Not Great at Preventing Migraines Either
Some people wonder whether their SSRI might at least be doing double duty by preventing migraines, given the serotonin connection. The evidence says no. A Cochrane systematic review examined 11 studies covering five different SSRIs and one SNRI, with a combined total of 585 participants. The conclusion was blunt: SSRIs showed no evidence of being more effective than placebo at reducing migraine frequency, intensity, or duration over two to three months of treatment.8PubMed Central. Selective serotonin reuptake inhibitors (SSRIs) and serotonin‐norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults
When SSRIs were compared head-to-head against amitriptyline, an older tricyclic antidepressant that has long been used for migraine prevention, the two classes performed similarly in some measures but amitriptyline came out ahead for reducing actual migraine attacks. One trial directly comparing citalopram to amitriptyline in patients with both depression and migraine found that while both drugs worked equally well for depressive symptoms, amitriptyline was more effective at cutting down migraine and tension-type headache attacks.9Neuropsychobiology. Evaluation of the Prophylactic Efficacy of Amitriptyline and Citalopram, Alone or in Combination, in Patients with Comorbidity of Depression, Migraine, and Tension-Type Headache
SNRIs, a related class that blocks reabsorption of both serotonin and norepinephrine, have somewhat better evidence. Venlafaxine and duloxetine show at least modest efficacy for migraine prevention and may be the most effective antidepressant option when depression and migraine coexist.10PubMed. Antidepressants for Preventive Treatment of Migraine If you need an antidepressant and also want migraine prevention, an SNRI or a tricyclic is a more evidence-backed choice than an SSRI. That said, SSRIs like fluoxetine have been described as “not effective for most patients” in terms of migraine prevention, which does not mean they make migraines worse for most people, just that they do not meaningfully help.
Taking Triptans While on an SSRI
If you use both an SSRI for depression and a triptan for acute migraine attacks, you have probably seen a warning about serotonin syndrome on one or both labels. The FDA issued an alert about this combination in 2006, and pharmacies routinely flag the interaction. The concern is that both drugs increase serotonin activity, and too much serotonin can cause a dangerous constellation of symptoms including agitation, rapid heartbeat, high body temperature, and muscle rigidity.
In practice, the risk turns out to be very low. A large study covering 14 years of data at a major medical center found that among nearly 19,000 patients who were prescribed both a triptan and an SSRI or SNRI, the estimated incidence of serotonin syndrome was 0 to 4 cases per 10,000 person-years of exposure.11JAMA Neurology. Association of Coprescription of Triptan Antimigraine Drugs and Selective Serotonin Reuptake Inhibitor or Selective Norepinephrine Reuptake Inhibitor Antidepressants With Serotonin Syndrome A separate analysis noted that roughly 700,000 patients annually take SSRIs or SNRIs alongside triptans, and millions have used the combination over the past decade without a surge in serotonin syndrome reports.12PubMed. Serotonin syndrome risks when combining SSRI/SNRI drugs and triptans: is the FDA’s alert warranted?
This does not mean you should ignore the warning entirely. It means you do not need to avoid triptans just because you are on an SSRI. Many headache specialists consider the combination safe for the vast majority of patients and argue that the FDA alert was disproportionate to the actual evidence of harm. If you are currently avoiding triptans for your migraines solely because of this concern, it is worth discussing the real risk numbers with your doctor.
Medication Overuse Headache and How SSRIs Fit In
Medication overuse headache is a pattern where taking too many acute headache treatments, typically more than 10 to 15 days per month, paradoxically increases headache frequency. It is one of the most common reasons episodic migraine evolves into chronic daily headache. The treatment involves withdrawing the overused medication, which itself causes a painful rebound period.
Here SSRIs may actually play a helpful role. A study published in Medicine examined whether SSRI use affected outcomes in patients being treated for medication overuse headache. Patients who were on an SSRI had a significantly lower risk of relapsing back into the overuse pattern. The hazard ratio for relapse was 0.255, meaning SSRI users were roughly a quarter as likely to relapse as those not on an SSRI.13PubMed Central. Effect of selective serotonin reuptake inhibitor treatment on the prognosis of patients with medication overuse headache The researchers suggested this might be because SSRIs helped address the underlying anxiety or depression that often drives overuse of acute headache medications in the first place. This is a single study and the finding needs replication, but it is a genuinely interesting wrinkle in the SSRI-headache story.
Why Depression and Migraine Travel Together
The overlap between depression and migraine is not a coincidence. Both conditions share underlying biology involving serotonin imbalances, genetic predisposition, hormonal fluctuations, and environmental triggers.14PubMed. Unraveling the connections between migraine and psychiatric comorbidities: A narrative review People with migraine are two to four times more likely to have depression than the general population, and the relationship is bidirectional: having one condition increases your risk of developing the other.
This comorbidity means that the question “is my SSRI causing my migraines?” is harder to untangle than it sounds. You started the SSRI for a reason, and the condition it is treating shares neurobiological pathways with migraine. Worsening migraines after starting an SSRI could reflect the medication itself, the natural progression of your migraine disease, increased stress from the condition being treated, sleep disruption from the SSRI, or simply the fact that you are now paying closer attention to your body because of a new medication. Sorting out which factor dominates usually requires working with your doctor and keeping a detailed headache diary for several weeks.
Genetics and Who Gets Headaches from SSRIs
Not everyone is equally susceptible to SSRI-related headaches, and genetics appear to play a role. Research examining polygenic risk scores, which combine the effects of many small genetic variations, found that people with a higher genetic predisposition to headaches were more likely to develop headaches when taking sertraline and, to a lesser extent, venlafaxine.15PubMed Central. Understanding genetic risk factors for common side effects of antidepressant medications In other words, your baseline headache tendency influences how your body responds to these drugs. If you already get frequent headaches or migraines, you may be more likely to experience headache as a side effect, which is consistent with what many migraine patients report anecdotally.
This genetic angle also suggests that the wide variation in headache experience between SSRI users is not random or imaginary. Two people on the same dose of the same SSRI can have completely different headache outcomes, and part of that difference is baked into their biology. Pharmacogenomic testing, while still evolving, may eventually help prescribers predict who is more likely to develop headaches from specific drugs before they start treatment.
The Picture Looks Different in Children and Adolescents
If you are a parent wondering whether your child’s SSRI might be causing headaches, the evidence is somewhat reassuring. A meta-analysis of side effects in children and adolescents treated with antidepressants found that headaches were not significantly associated with SSRI or SNRI treatment compared to placebo. Even more striking, the largest trial of SSRIs in pediatric anxiety (the CAMS study) found that SSRI-treated children actually reported fewer headaches over time. By week four, headaches had improved compared to baseline, and the improvement persisted through twelve weeks, while placebo did not significantly affect headache frequency.16PubMed Central. Adverse Effects of Antidepressant Medications and their Management in Children and Adolescents
One explanation for this finding is that childhood anxiety itself is a potent headache trigger. Treating the anxiety may reduce the headache burden more than the SSRI adds to it. This does not mean no child will ever get a headache from an SSRI, but it does mean that the adult pattern of slightly increased headache risk does not seem to carry over cleanly to the pediatric population.
Practical Steps if Your SSRI Seems to Be Triggering Migraines
If you have started an SSRI and your migraines have gotten worse, here is a reasonable approach:
- Track it: Keep a headache diary for at least four to six weeks. Note the date, severity, any aura, how long the headache lasted, and what medications you took. This gives you and your doctor actual data instead of impressions.
- Wait if you can: Many SSRI-related headaches settle within the first few weeks. If your migraines are manageable, waiting out the adjustment period is often the first recommendation.
- Review the dose: Sometimes a lower dose produces fewer side effects while still treating depression or anxiety. This is a conversation for your prescriber, not a DIY experiment.
- Consider switching drugs: If headaches persist beyond the adjustment period, switching to a different SSRI may help, since the meta-analysis showed different headache risk profiles across individual drugs. An SNRI like venlafaxine might also serve double duty by offering some migraine prevention alongside antidepressant effects.
- Treat the migraine directly: Using a triptan or other acute migraine treatment alongside your SSRI is safe for the vast majority of people, as discussed above. Do not suffer through migraines because of an interaction warning that sounds scarier than the data warrants.
- Never stop abruptly: If you and your doctor decide the SSRI needs to go, taper gradually to minimize the risk of rebound headaches and discontinuation symptoms.
Menopause, Hormones, and the SSRI-Migraine Intersection
Migraine patterns often shift dramatically during perimenopause and menopause, when fluctuating estrogen levels destabilize the neurovascular system. Women in this phase sometimes start SSRIs for mood symptoms and then notice changes in their migraine patterns that may or may not be medication-related. Distinguishing hormonal migraine shifts from drug side effects is particularly difficult during this period because both variables are moving at the same time.
There is limited evidence that escitalopram and venlafaxine may have some efficacy for managing symptoms during menopause in patients who cannot use hormone replacement therapy.17PubMed Central. Migraine, menopause and hormone replacement therapy For women dealing with both menopausal symptoms and migraine, the treatment calculus is genuinely complex. An SSRI might help the mood and hot-flash symptoms while doing nothing for or slightly worsening migraines, or the mood improvement might indirectly reduce migraine triggers like poor sleep and stress. This is an area where individualized treatment with a provider who understands both conditions matters more than any general recommendation.